MANKIND: FY26 revenue up 17% YoY, driven by chronic therapies and strong domestic growth
MANKIND: FY26 revenue up 17% YoY, driven by chronic therapies and strong domestic growth
MANKIND: FY26 revenue up 17% YoY, driven by chronic therapies and strong domestic growth
Sector
BROAD_MARKET
News Type
MARKET
Impact Level
HIGH
AI Sentiment
POSITIVE
Published
19 May 2026
📎 Sources
Quartr | https://www.tradingview.com/news/urn:summary_document_slides:quartr.com:3348027:0-mankind-fy26-revenue-up-17-yoy-driven-by-chronic-therapies-and-strong-domestic-growth/